根据IndexBox最新发布的全球疝修补器械市场报告，市场进入2026年时，需求基本面更为稳固，采购行为更趋理性，供应架构的区域分布也更加多元。随着全球医疗体系应对人口老龄化与肥胖率上升带来的疝病负担，全球疝修补器械市场正步入稳步的技术驱动扩张期。本报告对2026至2035年市场进行全面分析，覆盖疝修补所用的全品类产品，包括合成补片、生物补片与混合补片等植入物，缝线固定器械，腹腔镜与机器人器械，疝钉、吻合钉及机械固定器械，组织分离器，以及预包装疝修补套件。
According to IndexBox's latest global hernia repair devices market report, the market enters 2026 with more solid demand fundamentals, more rational procurement behavior, and more diverse regional supply architecture. As global healthcare systems address the hernia burden brought by aging populations and rising obesity rates, the global hernia repair devices market is entering a steady technology-driven expansion period. The report comprehensively analyzes the 2026–2035 market, covering the full range of products used in hernia repair, including synthetic, biological, and hybrid mesh implants, suture fixation devices, laparoscopic and robotic instruments, hernia tacks, staples and mechanical fixation devices, tissue separators, and pre-packaged hernia repair kits.
该市场的特点是手术量大、产品持续迭代，竞争格局由成熟的跨国企业主导。增长主要得益于微创与机器人辅助手术技术的持续普及，这类术式需要专用补片和固定器械，平均售价也更高。北美和欧洲等发达地区凭借先进的医疗基础设施和高手术量，继续占据最大的收入份额，亚太和拉美等新兴经济体的增速则最快，动力来自手术可及性改善和医疗支出增加。到2035年的预测期内，机器人手术的渗透、先进生物补片与可吸收合成补片的采用，以及医疗支付方日益加大的控费压力，将共同塑造市场走向。
The market is characterized by high surgical volume and continuous product iteration, with a competitive landscape dominated by established multinational corporations. Growth is mainly driven by the continued adoption of minimally invasive and robot-assisted surgical techniques—these procedures require specialized mesh and fixation devices at higher average selling prices. Developed regions including North America and Europe continue to hold the largest revenue share thanks to advanced medical infrastructure and high surgical volumes, while emerging economies in Asia-Pacific and Latin America grow fastest, driven by improved surgical access and increased healthcare spending. Through the 2035 forecast period, robotic surgery penetration, adoption of advanced biological and absorbable synthetic meshes, and growing payer cost-control pressure will jointly shape market direction.
基准情景预计，全球疝修补器械市场将在2035年前保持增长，2026至2035年复合年增长率为4.2%，市场指数升至152（2025年=100）。这一展望建立在支撑手术量的基本人口与临床趋势之上，全球人口老龄化、肥胖患病率上升，以及微创手术技术的加速普及。由于手术率高、医疗基础设施先进，市场收入仍将主要集中于北美和欧洲，两地合计占全球收入的多数。不过，增长最具活力的将是亚太和拉美地区，手术可及性改善、医疗旅游发展和医疗支出上升预计将推动当地需求。
The baseline scenario projects the global hernia repair devices market will maintain growth through 2035, with a 4.2% compound annual growth rate from 2026 to 2035 and a market index rising to 152 (2025=100). This outlook is built on fundamental demographic and clinical trends supporting surgical volume—global population aging, rising obesity prevalence, and accelerated adoption of minimally invasive surgical techniques. Due to high surgical rates and advanced medical infrastructure, market revenue will remain mainly concentrated in North America and Europe, which together account for the majority of global revenue. However, the most dynamic growth will be in Asia-Pacific and Latin America, where improved surgical access, medical tourism development, and rising healthcare spending are expected to drive local demand.
产品结构将持续演变，机器人辅助手术和先进生物补片将逐步抢占传统合成补片与开放手术的份额。医疗支付方的控费压力，尤其在发达市场，将抑制价格上行，但随着手术量继续增加，整体市场扩张不太可能受到明显拖累。竞争格局方面，头部企业之间的角逐预计将持续，战略重点包括产品组合多元化、地域扩张和有针对性的并购。补片安全性相关的监管审查仍是主要风险因素，但总体走势指向由创新引领的稳步增长，直至2035年。
Product structure will continue evolving, with robot-assisted surgery and advanced biological meshes gradually taking share from traditional synthetic meshes and open surgery. Payer cost-control pressure, especially in developed markets, will restrain price increases, but as surgical volume continues rising, overall market expansion is unlikely to be significantly dragged down. On the competitive landscape, competition among leading enterprises is expected to continue, with strategic priorities including product portfolio diversification, geographic expansion, and targeted M&A. Regulatory scrutiny related to mesh safety remains a major risk factor, but the overall trend points to innovation-led steady growth through 2035.
报告按终端应用行业划分了需求结构。腹股沟疝修补估计份额42%，仍是最大的应用细分，需求动力来自腹股沟疝的高患病率，尤其是老年男性，以及从开放无张力修补向腹腔镜和机器人辅助技术的持续转变。腹壁疝与切口疝修补估计份额28%，是一个复杂且不断增长的细分，动力来自腹部手术数量上升及相关的切口疝风险。食管裂孔疝修补估计份额12%，与胃食管反流病的管理密切相关，越来越多地通过腹腔镜和机器人术式完成。股疝与脐疝修补估计份额10%，需求由人口老龄化和肥胖患病率上升驱动。儿童疝与复发疝修补估计份额8%，器械要求独特，市场规模有限但专业性强。
The report divides demand structure by end-use industry. Inguinal hernia repair, estimated at 42% share, remains the largest application segment, driven by the high prevalence of inguinal hernias, especially in older men, and the continued shift from open tension-free repair to laparoscopic and robot-assisted techniques. Abdominal wall and incisional hernia repair, estimated at 28%, is a complex and growing segment driven by rising abdominal surgery volumes and associated incisional hernia risk. Hiatal hernia repair, estimated at 12%, is closely related to GERD management and increasingly performed via laparoscopic and robotic approaches. Femoral and umbilical hernia repair, estimated at 10%, is driven by population aging and rising obesity prevalence. Pediatric and recurrent hernia repair, estimated at 8%, has unique device requirements with limited market size but strong specialization.
区域动态方面，北美估计份额38%，仍是最大市场，动力来自高手术量、先进医疗基础设施和机器人辅助手术的快速采用。欧洲估计份额27%，是成熟市场，腹腔镜和机器人手术渗透率高，增长受人口老龄化和肥胖率上升支撑，但受医疗预算压力和各国报销政策差异制约。亚太估计份额22%，是增长最快的地区，动力来自手术可及性改善、医疗支出上升和医疗旅游发展。拉美估计份额8%，显示出温和增长潜力。中东和非洲估计份额5%，是新兴市场，需求增长动力来自海湾国家的医疗投资增加和手术能力改善。
On regional dynamics, North America, estimated at 38% share, remains the largest market, driven by high surgical volume, advanced medical infrastructure, and rapid adoption of robot-assisted surgery. Europe, estimated at 27%, is a mature market with high laparoscopic and robotic surgery penetration; growth is supported by aging and rising obesity but constrained by healthcare budget pressure and varying national reimbursement policies. Asia-Pacific, estimated at 22%, is the fastest-growing region, driven by improved surgical access, rising healthcare spending, and medical tourism development. Latin America, estimated at 8%, shows moderate growth potential. Middle East and Africa, estimated at 5%, is an emerging market with demand growth driven by increased healthcare investment in Gulf countries and improved surgical capacity.
这份报告和前面讨论的手术机器人市场有交集。前面讨论过IndexBox的神经外科机器人手术系统市场报告，预测2026至2035年复合年增长率8.2%，到2035年市场指数220。疝修补器械市场4.2%的增速，比神经外科机器人市场低了一半。这个差异说明，疝修补器械是一个更成熟、增速更平稳的市场，它的增长主要来自手术量增加和产品结构升级，而不是像神经外科机器人那样由技术渗透率快速提升驱动。前面也讨论过MMI的显微外科机器人拿到1.25亿美元D轮，Butterfly Network和Bridge Neurotech用超声做非侵入式脑机接口，凯瑞医疗的智能采血机器人拿到三类证。这些都是在手术和诊断环节的新技术尝试。疝修补器械市场的报告，呈现的是另一个视角，一个已经成熟的手术品类，在机器人手术普及的推动下，正在经历产品结构的渐进式升级。
This report intersects with the surgical robot market discussed earlier. Earlier we discussed IndexBox's neurosurgery robotic surgical systems market report, projecting an 8.2% CAGR from 2026 to 2035 and a market index of 220 by 2035. The hernia repair devices market's 4.2% growth rate is half that of the neurosurgery robot market. This difference indicates hernia repair devices is a more mature, steadier-growth market, with growth mainly from increased surgical volume and product structure upgrades rather than rapid technology penetration-driven growth like neurosurgery robots. Earlier we also discussed MMI's microsurgery robot raising a $125 million Series D, Butterfly Network and Bridge Neurotech using ultrasound for non-invasive BCI, and Kairui Medical's intelligent blood collection robot obtaining Class III certification. These are new technology attempts in surgical and diagnostic links. The hernia repair devices market report presents another perspective—a already-mature surgical category undergoing gradual product structure upgrades driven by robotic surgery adoption.
